Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0GY4H
|
||||
Former ID |
DNCL001718
|
||||
Drug Name |
Taberminogene vadenovec
|
||||
Synonyms |
Trinam (TN)
|
||||
Indication | Vascular restinosis following vascular graft surgery [ICD10:T82.858A] | Phase 3 | [522657] | ||
Company |
Ark Therapeutics
|
||||
Target and Pathway | |||||
Target(s) | Vascular endothelial growth factor receptor 3 | Target Info | Modulator | [532990] | |
NetPath Pathway | TNFalpha Signaling Pathway | ||||
Pathway Interaction Database | VEGF and VEGFR signaling network | ||||
VEGFR3 signaling in lymphatic endothelium | |||||
WikiPathways | Signaling by VEGF | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.